Rocuronium reversed by sugammadex versus mivacurium during high-risk eye surgery: An institutional anaesthetic practice evaluation

Journal of International Medical Research

Volumn 41, Issue 5, 2013, Pages 1740-1751

  von Quillfeldt, Susanne ^a   Föhre, Bettina ^a   Andrees, Nicolai ^a   Spies, Claudia D ^a   Galvagni, Daniele ^b   Joussen, Antonia M ^b   Wernecke, Klaus D ^c   Boemke, Willehad ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c SOSTANA GMBH   (Germany)

Author keywords

Anaesthesia; curarization; general; ophthalmology; patient safety; reversal

Indexed keywords

DIPYRONE; MIDAZOLAM; MIVACURIUM; OPIATE; PARACETAMOL; PIRITRAMIDE; PROPANOL; PROPOFOL; REMIFENTANIL; ROCURONIUM; SUGAMMADEX;

ADULT; ANESTHESIA INDUCTION; ARTICLE; ASPIRATION; CLINICAL ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; EXTUBATION; EYE SURGERY; FEMALE; HIGH RISK PATIENT; HUMAN; INTRAVENOUS ANESTHESIA; MALE; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; OBSERVATIONAL STUDY; PATIENT CARE; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PREMEDICATION;

ANAESTHESIA; CURARIZATION; GENERAL; OPHTHALMOLOGY; PATIENT SAFETY; REVERSAL;

ADULT; AGED; AIRWAY EXTUBATION; ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; ANESTHESIA, GENERAL; ANESTHETICS; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; OPHTHALMOLOGIC SURGICAL PROCEDURES; QUESTIONNAIRES; TIME FACTORS;

EID: 84887273306     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513489476     Document Type: Article

References (46)

1. Tan DT,Dart JK,Holland EJ, et al.Corneal transplantation.Lancet. 2012;379:1749-1761.
2. Machemer R,Buettner H,Norton EW, et al.Vitrectomy: a pars plana approach.Trans Am Acad Ophthamol Otolaryngol. 1971;75:813-820.
3. Augustin AJ,Offermann I.Scope and limitations of innovative vitrectomy systems.Klin Monatsbl Augenheilkd. 2007;224:707-715.
4. Federal Bureau of Statistics. DRG statistics 2011: Operations and procedures on the basis of the 4 lettered OPS for in-patients and patients in hospitals. Statistisches Bundesamt, Wiesbaden, 2012. Available at: https://www.destatis.de/DE/Publikationen/Thematisch/Gesundheit/Krankenhaeuser/OperationenProzeduren5231401117014.pdf?__blob = publicationFile. [In German]. Accessed December 2012.
5. Rossiter JD,Wood M,Lockwood A, et al.Operating conditions for ocular surgery under general anaesthesia: an eccentric problem.Eye. 2006;20:55-58.
6. Jaichandran V.Ophthalmic regional anaesthesia: A review and update.Indian J Anaesth. 2013;57:7-13.
7. American Society of Anesthesiologists physical status classification system. Available at: http://www.asahq.org/Home/For-Members/Clinical-Information/ASA-Physical-Status-Classification-System. Accessed 18 June 2013.
8. Dornberger I,Kastrup MCheck-up Anästhesiologie. 2nd edn. Heidelberg: Springer, 2005, pp. 223-243.Kox WJSpies CD, ed. Heidelberg: Springer; 2005:223-243.
9. Buzello W,Diefenbach C,Nigrovic V.Muscle relaxants: a clinical update.Acta Anaesthesiol Scand Suppl. 1996;109:165-167.
10. Claudius C,Viby-Mogensen J.Acceleromyography for use in scientific and clinical practice, a systematic review of the evidence.Anesthesiology. 2008;108:1117-1140.
11. Sparr HJ,Vermeyen KM,Beaufort AM, et al.Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety and pharmacokinetics.Anesthesiology. 2007;106:935-943.
12. Naguib M.Sugammadex: Another milestone in clinical neuromuscular pharmacology.Anesth Analg. 2007;104:575-581.
13. Ledowski T,Hillyard S,Kozman A, et al.Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs.Anaesth Intensive Care. 2012;40:340-343.
14. Chambers D,Paulden M,Paton F, et al.Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.Health Technol Assess. 2010;14:1-211.
15. Bhananker SM,Posner KL,Cheney FW, et al.Injury and liability associated with monitored anesthesia care: a closed claims analysis.Anesthesiology. 2006;104:228-234.
16. Radtke FM,Franck M,Schneider M, et al.Comparison of three scores to screen for delirium in the recovery room.Br J Anaesth. 2008;101:338-343.
17. Murphy GS,Szokol JW,Marymont JH, et al.Residual paralysis at the time of tracheal extubation.Anesth Analg. 2005;100:1840-1845.
18. Grayling M,Sweeney BP.Recovery from neuromuscular blockade: a survey of practice.Anaesthesia. 2007;62:806-809.
19. Fuchs-Buder T,Hofmockel R,Geldner G, et al.[The use of neuromuscular monitoring in Germany].Anaesthesist. 2003;52:522-526.
20. Sorgenfrei IF,Viby-Mogensen J,Swiatek FA.Does evidence lead to a change in clinical practice? Danish anaesthetists' and nurse anaesthetists' clinical practice and knowledge of postoperative residual curarization.Ugeskr Laeg. 2005;167:3878-3882.
21. Arbous MS,Meursing AE,van Kleef JW, et al.Impact of anesthesia management characteristics on severe morbidity and mortality.Anesthesiology. 2005;102:257-268.
22. Sundman E,Witt H,Olsson R, et al.The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium.Anesthesiology. 2000;92:977-984.
23. Eriksson LI,Sundman E,Olsson R, et al.Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers.Anesthesiology. 1997;87:1035-1043.
24. Isono S,Ide T,Kochi T, et al.Effects of partial paralysis on the swallowing reflex in conscious humans.Anesthesiology. 1991;75:980-984.
25. Eriksson LI,Sato M,Severinghaus JW.Effect of a vecuronium-induced partial neuromuscular block on hypoxic ventilatory response.Anesthesiology. 1993;78:693-699.
26. Eriksson LI,Lennmarken C,Wyon N, et al.Attenuated ventilatory response to hypoxaemia at vecuronium-induced partial neuromuscular block.Acta Anaesthesiol Scand. 1992;36:710-715.
27. Eriksson L.Reduced hypoxic chemosensitivity in partially paralysed man.A new property of muscle relaxants. Acta Anaesthesiol Scand. 1996;40:520-523.
28. Kopman AF,Yee PS,Neuman GG.Correlation of the train-of-four fade ratio with clinical signs and symptoms of residual curarization in awake volunteers.Anesthesiology. 1997;86:765-771.
29. Mortensen CR,Berg H,El Mahdy A, et al.Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium.Acta Anaesthesiol Scand. 1995;39:797-801.
30. Viby-Mogensen J,Jensen E,Werner M, et al.Measurement of acceleration: A new method of monitoring neuromuscular function.Acta Anaesthesiol Scand. 1988;32:45-48.
31. Ansermino JM,Sanderson PM,Bevan JC, et al.Acceleromyography improves detection of residual neuromuscular blockade in children.Can J Anaesth. 1996;43:589-594.
32. Gätke MR,Viby-Mogensen J,Rosenstock C, et al.Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used.Acta Anaesthesiol Scand. 2002;46:207-213.
33. Baillard C,Clec'h C,Catineau J, et al.Postoperative residual neuromuscular block: a survey of management.Br J Anaesth. 2005;95:622-626.
34. Ali HH,Wilson RS,Savarese JJ, et al.The effect of tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans.Br J Anaesth. 1975;47:570-574.
35. Capron F,Alla F,Hottier C, et al.Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9.Anesthesiology. 2004;100:1119-1124.
36. Eikermann M,Groeben H,Hüsing J, et al.Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade.Anesthesiology. 2003;98:1333-1337.
37. Viby-Mogensen J,Jensen NH,Engbaek J, et al.Tactile and visual evaluation of the response to train-of-four nerve stimulation.Anesthesiology. 1985;63:440-443.
38. Frampton JE,McTavish D.Mivacurium.A review of its pharmacology and therapeutic potential in general anaesthesia. Drugs. 1993;45:1066-1089.
39. Kirkegaard-Nielsen H,Helbo-Hansen HS,Lindholm P, et al.Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade.Can J Anaesth. 1996;43:932-938.
40. Jahr JS,Keller T,Williams MD, et al.To reverse or not to reverse: an evaluation of reversal of mivacurium chloride in women undergoing outpatient gynecological procedures.Am J Ther. 1997;4:315-322.
41. Ting CK,Lin SM,Yang YW, et al.Reversal of mivacurium chloride: edrophonium of spontaneous recovery in microscopic laryngeal surgery.Acta Anaesthesiol Sin. 2001;39:157-162.
42. Gottlieb JD,Sweet RB.The antagonism of curare: the cardiac effects of atropine and neostigmine.Can Anaesth Soc J. 1963;10:114-121.
43. Pratt CI.Bronchospasm after neostigmine.Anaesthesia. 1988;43:248-248.
44. Taylor PGoodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw-Hill, Inc, 2005, pp. 201-216.Brunton LLazo JParker K, ed. New York: McGraw-Hill, Inc; 2005:201-216.
45. Løvstad RZ,Thagaard KS,Berner NS, et al.Neostigmine 50 μg/kg with glycopyrrolate increases postoperative nausea in women after laparoscopic gynaecological surgery.Acta Anaesthesiol Scand. 2001;45:495-500.
46. Nelskylä K,Yli-Hankala A,Soikkeli A, et al.Neostigmine with glycopyrrolate does not increase the incidence or severity of postoperative nausea and vomiting in outpatients undergoing gynaecological laparoscopy.Br J Anaesth. 1998;81:757-760.